SKIP (Supporting Kids with diabetes In Physical activity): Feasibility of a randomised controlled trial of a digital intervention for 9-12 year olds with type 1 diabetes mellitus.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
03 Apr 2019
Historique:
received: 29 06 2018
accepted: 25 03 2019
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 22 5 2019
Statut: epublish

Résumé

Physical activity and self-monitoring are important for children with type 1 diabetes mellitus (T1DM) but it is unclear whether interventions delivered online are feasible, acceptable to patients and efficacious. The aim was to assess the feasibility and acceptability of an internet-based physical activity and self-monitoring programme for children with T1DM, and of a randomised controlled trial (RCT) to evaluate efficacy. A total of 49 children aged 9-12 with T1DM were randomly assigned to usual care only or to an interactive intervention group combining a website (STAK-D) and a PolarActive activity watch (PAW; Polar Electro (UK) Ltd.), alongside usual care. Participants completed self-report measures on their health, self-efficacy and physical activity at baseline (T0), eight weeks (T1) and six months (T2). They also wore a PAW to measure physical activity for one week at the end of T0, T1 and T2. Intervention participants were interviewed about their experiences at T2. Explanatory variables were examined using multi-level modelling and examination of change scores, 95% confidence intervals and p-values with alpha set at 0.95. Descriptive analysis was undertaken of the 'end-of-study questionnaire'. Qualitative analysis followed a framework approach. Completion rates for all self-report items and objective physical activity data were above 85% for the majority of measures. HbA1c data was obtained for 100% of participants, although complete clinical data was available for 63.3% to 63.5% of participants at each data collection time-point. Recruitment and data collection processes were reported to be acceptable to participants and healthcare professionals. Self-reported sedentary behaviour (-2.28, p=0.04, 95% CI=-4.40, -0.16; p = 0.04; d The trial design was feasible and acceptable to participants and healthcare providers. Intervention engagement was low and technical challenges were evident in both online and activity watch elements, although enjoyment was high among users. Reported outcome improvements were observed at 8 weeks but were not sustained. ISRCTN 48994721 (prospectively registered). Date of registration: 28.09.2016.

Sections du résumé

BACKGROUND BACKGROUND
Physical activity and self-monitoring are important for children with type 1 diabetes mellitus (T1DM) but it is unclear whether interventions delivered online are feasible, acceptable to patients and efficacious. The aim was to assess the feasibility and acceptability of an internet-based physical activity and self-monitoring programme for children with T1DM, and of a randomised controlled trial (RCT) to evaluate efficacy.
METHODS METHODS
A total of 49 children aged 9-12 with T1DM were randomly assigned to usual care only or to an interactive intervention group combining a website (STAK-D) and a PolarActive activity watch (PAW; Polar Electro (UK) Ltd.), alongside usual care. Participants completed self-report measures on their health, self-efficacy and physical activity at baseline (T0), eight weeks (T1) and six months (T2). They also wore a PAW to measure physical activity for one week at the end of T0, T1 and T2. Intervention participants were interviewed about their experiences at T2. Explanatory variables were examined using multi-level modelling and examination of change scores, 95% confidence intervals and p-values with alpha set at 0.95. Descriptive analysis was undertaken of the 'end-of-study questionnaire'. Qualitative analysis followed a framework approach.
RESULTS RESULTS
Completion rates for all self-report items and objective physical activity data were above 85% for the majority of measures. HbA1c data was obtained for 100% of participants, although complete clinical data was available for 63.3% to 63.5% of participants at each data collection time-point. Recruitment and data collection processes were reported to be acceptable to participants and healthcare professionals. Self-reported sedentary behaviour (-2.28, p=0.04, 95% CI=-4.40, -0.16; p = 0.04; d
CONCLUSIONS CONCLUSIONS
The trial design was feasible and acceptable to participants and healthcare providers. Intervention engagement was low and technical challenges were evident in both online and activity watch elements, although enjoyment was high among users. Reported outcome improvements were observed at 8 weeks but were not sustained.
TRIAL REGISTRATION BACKGROUND
ISRCTN 48994721 (prospectively registered). Date of registration: 28.09.2016.

Identifiants

pubmed: 30943939
doi: 10.1186/s12889-019-6697-1
pii: 10.1186/s12889-019-6697-1
pmc: PMC6446303
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

371

Subventions

Organisme : Department of Health
ID : PB-PG-0215-36024
Pays : United Kingdom
Organisme : Research for Patient Benefit Programme
ID : PB-PG-0215-36024

Références

J Epidemiol Community Health. 2005 Jan;59(1):75-82
pubmed: 15598731
Acta Paediatr. 2005 Oct;94(10):1395-1401
pubmed: 16299869
Med Sci Sports Exerc. 2008 Apr;40(4):767-72
pubmed: 18317366
Scand J Med Sci Sports. 2009 Oct;19(5):740-7
pubmed: 18694433
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Health Psychol. 2009 Nov;28(6):690-701
pubmed: 19916637
Qual Health Res. 2010 Mar;20(3):340-51
pubmed: 20054040
Int J Behav Nutr Phys Act. 2011 Jun 20;8:64
pubmed: 21689396
BMC Public Health. 2011 Oct 26;11:830
pubmed: 22029547
J Clin Epidemiol. 2012 Mar;65(3):301-8
pubmed: 22169081
Diabetologia. 2012 Nov;55(11):2895-905
pubmed: 22890825
J Med Internet Res. 2013 Mar 19;15(3):e48
pubmed: 23512442
Pediatr Diabetes. 2014 May;15(3):175-89
pubmed: 23895512
Pediatr Diabetes. 2015 Feb;16(1):48-57
pubmed: 24444038
J Phys Act Health. 2015 Feb;12(2):232-7
pubmed: 24508755
J Adolesc Health. 2014 Jun;54(6):631-45
pubmed: 24534357
West J Nurs Res. 2015 Mar;37(3):288-98
pubmed: 24622154
Int J Behav Nutr Phys Act. 2014 Apr 08;11(1):49
pubmed: 24708604
Prev Chronic Dis. 2014 May 22;11:E85
pubmed: 24854236
BMJ. 2014 May 27;348:g3256
pubmed: 24865166
BMJ Open. 2014 Jun 26;4(6):e005295
pubmed: 24969784
Med Sci Sports Exerc. 2015 Apr;47(4):765-74
pubmed: 25051389
Nurs Child Young People. 2015 Feb;27(1):16-21
pubmed: 25671752
BMJ Open. 2016 Jan 06;6(1):e009318
pubmed: 26739729
Int J Behav Nutr Phys Act. 2016 Feb 18;13:25
pubmed: 26892920
Am J Health Behav. 2016 Jul;40(4):472-83
pubmed: 27338994
Curr Diab Rep. 2016 Sep;16(9):85
pubmed: 27475093
Trials. 2016 Dec 8;17(1):583
pubmed: 27931254
J Diabetes Res. 2017;2017:1708148
pubmed: 28232949
Musculoskelet Sci Pract. 2017 Aug;30:10-17
pubmed: 28494261
PLoS One. 2017 Jun 2;12(6):e0178539
pubmed: 28575026
BMC Endocr Disord. 2019 Jan 10;19(1):7
pubmed: 30630442
Diabetes Care. 1987 Sep-Oct;10(5):617-21
pubmed: 3677982
Fam Process. 1998 Summer;37(2):127-51
pubmed: 9693946

Auteurs

Emily Knox (E)

University of Nottingham, School of Health Sciences, Nottingham, UK.

Cris Glazebrook (C)

University of Nottingham, School of Medicine, Nottingham, UK.
NIHR MindTech MedTech Co-operative, Institute of Mental Health, University of Nottingham, Triumph Road, Nottingham, UK.

Tabitha Randell (T)

Nottingham University Hospitals NHS Trust, Nottingham, UK.

Paul Leighton (P)

University of Nottingham, School of Medicine, Nottingham, UK.

Boliang Guo (B)

University of Nottingham, School of Medicine, Nottingham, UK.

James Greening (J)

University Hospitals of Leicester NHS Trust, Leicester, UK.

E Bethan Davies (EB)

University of Nottingham, School of Medicine, Nottingham, UK.
NIHR MindTech MedTech Co-operative, Institute of Mental Health, University of Nottingham, Triumph Road, Nottingham, UK.

Lori Amor (L)

NIHR MindTech MedTech Co-operative, Institute of Mental Health, University of Nottingham, Triumph Road, Nottingham, UK.

Holly Blake (H)

University of Nottingham, School of Health Sciences, Nottingham, UK. holly.blake@nottingham.ac.uk.
NIHR Nottingham Biomedical Research Centre, Nottingham, UK. holly.blake@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH